Market Tracker

01/29 9:04am ET

Myriad Genetics Inc (NASDAQ:MYGN)

37.79
Data as of Jan 28
 -0.08 / -0.21%
Today’s Change
25.57
Today|||52-Week Range
42.50
+10.95%
Year-to-Date

Today’s Trading

Previous close37.87
Today’s open37.87
Day’s range-- - --
Volume752,659
Average volume (3 months)839,243
Market cap$2.8B
Dividend yield--
Data as of 01/28/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-24.32%
Earnings growth (next 5 years)+14.91%
Revenue growth (last year)+26.92%
P/E ratio21.2
Price/Sales3.31
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.77-1.98%
--Cosmo Pharmaceutical...-11.95-6.38%
NBIXNeurocrine Bioscienc...-0.15-0.45%
MNKDMannkind Corp-0.13-1.97%
Data as of 01/28/2015

Financials

Next reporting dateFebruary 3, 2015
EPS forecast (this quarter)$0.34
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts